We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

How will astronauts make medicines in space?

What role have small molecules played in the fight against COVID-19?

Ensuring that options for patients living with rare diseases aren’t scarce.

Cell and gene therapy manufacturing technologies and methods are advancing rapidly, but can regulators keep up?

US Army combat veteran Luis Alvarez has developed a new drug delivery technology that can convert recombinant proteins into material-binding variants.

New approaches are underway for treating nonalcoholic steatohepatitis.

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.